Our Story
It began with a vision — to redefine cancer treatment by merging precision diagnostics with drug development. Recognizing the urgent need for therapies tailored to individual patients, Welmedis set out to bridge the gap between newly identified cancer targets and treatment, ensuring that every breakthrough in research translated into real-world impact.
This mission took shape through the fusion of cutting-edge technology and scientific expertise, which became the foundation for accelerating the development of next-generation therapies. But innovation alone wasn’t enough. The key was integration — bringing together molecular insights and drug discovery to create highly targeted treatments for specific cancer types. To achieve this, we built a powerhouse of collaboration. Our specialized laboratories in Germany, Switzerland, and Greece, together with expert CROs, create a dynamic network dedicated to pushing the boundaries of oncology research.
Our Mission
At Welmedis, our mission is to transform cancer therapy by developing targeted cancer therapeutics. We are dedicated to developing novel medications that target the unique characteristics of each patient’s cancer, offering more effective and tailored therapeutic solutions.
Who we are
Get to know the expert teams that work together across three European countries to create powerful synergies in research and development, improving outcomes for cancer patients with new personalized treatments.
What we do
Each team is made up of experts in their fields, working to further oncology research and drug development. Learn more about our work and the cutting-edge techniques we use.
Learn more about our ongoing projects
If you would like to know more about our ongoing projects, visit our Pipeline.